Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.920
-0.160 (-5.19%)
At close: Feb 21, 2025, 4:00 PM
3.000
+0.080 (2.74%)
After-hours: Feb 21, 2025, 5:59 PM EST
Compass Therapeutics Employees
Compass Therapeutics had 32 employees as of December 31, 2023. The number of employees increased by 6 or 23.08% compared to the previous year.
Employees
32
Change (1Y)
6
Growth (1Y)
23.08%
Revenue / Employee
$26,563
Profits / Employee
-$1,492,406
Market Cap
401.76M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 32 | 6 | 23.08% |
Dec 31, 2022 | 26 | 2 | 8.33% |
Dec 31, 2021 | 24 | -7 | -22.58% |
Dec 31, 2020 | 31 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
CMPX News
- 2 months ago - Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer - GlobeNewsWire
- 2 months ago - Compass Therapeutics: Near-Term Readout, But Beware The High Stakes In Biliary Cancer - Seeking Alpha
- 2 months ago - Compass Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Compass Therapeutics to Participate in Upcoming Investor Events - GlobeNewsWire
- 3 months ago - Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting - GlobeNewsWire
- 5 months ago - Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting - GlobeNewsWire
- 7 months ago - Compass Therapeutics to Participate in the Wedbush PacGrow Healthcare Conference - GlobeNewsWire